DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/03/3110-1227-1234$20.00
DMD 31:1227-1234, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K.-A.
Right arrow Articles by Shin, J.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K.-A.
Right arrow Articles by Shin, J.-G.

STEREOSELECTIVE METABOLISM OF LANSOPRAZOLE BY HUMAN LIVER CYTOCHROME P450 ENZYMES

Kyoung-Ah Kim, Min-Jung Kim, Ji-Young Park, Ji-Hong Shon, Young-Ran Yoon, Sang-Seop Lee, Kwang-Hyeon Liu, Jin-Ho Chun, Myung-Ho Hyun, and Jae-Gook Shin

Department of Pharmacology and Pharmacogenomics Research Center (K.-A.K., M.-J.K., J.-Y.P., J.-H.S., Y.-R.Y., S.-S.L., K.-H.L., J.-G.S.), and Department of Preventive Medicine (J.-H.C.), Inje University College of Medicine and Clinical Pharmacology Center, Busan Paik Hospital; and Department of Chemistry, Pusan National University (M.-H.H.), Busan, Korea

The stereoselective metabolism of lansoprazole enantiomers was evaluated by incubation of human liver microsomes and cDNA-expressed cytochrome P450 (P450) enzymes to understand and predict their stereoselective disposition in humans in vivo. The intrinsic clearances (Clint) of the formation of both hydroxy and sulfone metabolites from S-lansoprazole were 4.9- and 2.4-fold higher than those from the R-form, respectively. The sums of formation Clint of both metabolites were 13.5 and 57.3 µl/min/mg protein for R- and S-lansoprazole, respectively, suggesting that S-lansoprazole would be cleared more rapidly than the R-form. The P450 isoform selective inhibition study in liver microsomes, and the incubation study of cDNA-expressed enzymes, demonstrated that the stereoselective sulfoxidation is mediated by CYP3A4 and that the hydroxylation is mediated by CYP2C9 and CYP3A4 as well as by CYP2C19. Total Clint values of hydroxy and sulfone metabolite formation catalyzed by all these P450 enzymes were consistently higher for S-lansoprazole than for the R-form. The CYP3A4 produced the greatest difference of Clint between S- and R-enantiomers, mainly due to a difference of sulfoxidation metabolism (Clint 76.5 versus 10.8 µl/min/nmol of P450, respectively), whereas CYP2C19-catalyzed hydroxylation resulted in a minor difference of Clint between S- and R-enantiomers (179.6 versus 143.3 µl/min/nmol of P450, respectively). However, the affinity of CYP2C19 on hydroxylation was 5.7-fold higher for S-enantiomer than for the R-form (Km 2.3 versus 13.1 µM), suggesting that the role of CYP2C19 on stereoselective hydroxylation would be more prominent at concentrations around the usual therapeutic level. These findings suggest that both CYP2C19 and CYP3A4 are major enzymes contributing to the stereoselective disposition of lansoprazole, but stereoselective hydroxylation of lansoprazole enantiomers is mainly influenced by CYP2C19, especially at the usual therapeutic doses.


Address correspondence to: Dr. Jae-Gook Shin, Associate Professor of Pharmacology, Director, Pharmacogenomics Research Center, Inje University College of Medicine Clinical Pharmacology Center, Busan Paik Hospital # 633-165, Gaegum-Dong, Jin-Gu Busan 614-735, South Korea. E-mail: phshinjg{at}inje.ac.kr




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
H.-K. Lee, J.-K. Moon, C.-H. Chang, H. Choi, H.-W. Park, B.-S. Park, H.-S. Lee, E.-C. Hwang, Y.-D. Lee, K.-H. Liu, et al.
STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
Drug Metab. Dispos., July 1, 2006; 34(7): 1090 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K.-H. Liu, M.-J. Kim, W. M. Jung, W. Kang, I.-J. Cha, and J.-G. Shin
LANSOPRAZOLE ENANTIOMER ACTIVATES HUMAN LIVER MICROSOMAL CYP2C9 CATALYTIC ACTIVITY IN A STEREOSPECIFIC AND SUBSTRATE-SPECIFIC MANNER
Drug Metab. Dispos., February 1, 2005; 33(2): 209 - 213.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
N. Yasui-Furukori, M. Saito, T. Uno, T. Takahata, K. Sugawara, and T. Tateishi
Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes
J. Clin. Pharmacol., November 1, 2004; 44(11): 1223 - 1229.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.